P Hyperbaric Chamber Equipment and Consulting
Support Program. This, zero-risk, fixed-fee program is
designed to compliment, expand and support an existing
Wound Care Program. LST provides all of the equipment,
software and on-offsite training necessary to provide YOUR
staff with the capability, skills and confidence needed to
successfully operate a safe, efficient, and cost effective
adjunctive hyperbaric service. The result is the same
clinically
and financially successful hyperbaric oxygen
therapy
service as found in the full, turn-key, LST contract
management operations referred to below - only operated
and
managed by YOUR LST-trained staff. LST specialists
provide ongoing support throughout the contract period to
optimize performance.
P Hyperbaric Medicine Management & Staffing
Program. This zero-risk, fixed-fee, hyperbaric
management program is designed to compliment, expand
and support an existing Wound Care Program. LST will
furnish your hospital with the
equipment and personnel
necessary to help improve an
existing chronic wound
program and operate the hyperbaric
medicine operation.
LST full-time on-site personnel at your
hospital will consist
of a nurse manager and certified
technicians to operate the
unit during normal business hours
and to provide off-hours
emergency services.
• Most Profitable Hyperbaric Medicine and Chronic
Wound Care Program available.
• Fixed-Price and Zero Risk Contract Performance
Structure protects both parties.
• Positive Cash-flow within 60 days with no direct
startup charges to Hospital.
• LST Contracts meet STARK regulations, CMS,
JCAHO and OIG Guidelines.
• National Board Certified Hyperbaric and EMT
trained Technicians.
• LST is an International Leader in Chronic Wound
& Hyperbaric Technologies
.
• LST Staff are active members of the
international UHMS, NFPA, and ASME Safety
committees.
• Air-conditioned Monoplace Hyperbaric chambers
improve patient compliance.
• LST Patented LASER Targeted Digital Camera
wound documentation system.
• Computer-based Patient Wound care and HBOT
Treatment Tracking System.
|
How your hospital will benefit from an BACK TO TOP
LST Hyperbaric Medicine Program.
In this era of rapidly changing medical service reimbursement, most Article-28 medical institutions are seeking to develop new profit centers that are clinically effective, involve minimal risk, and that fit within the overall goals of the hospital while meeting community needs.
The need for a clinically effective chronic wound treatment service is evident in any community, especially in areas with older patient populations. Advancements in chronic wound treatment technology, particularly in the adjunctive use of Hyperbaric Oxygen Therapy (HBOT) have dramatically improved the resolution rates of even the most refractory chronic wounds.
The timely use of adjunctive HBOT can often significantly delay or even eliminate the need for limb amputations over a patient lifetime while actually increasing the total numbers of vascular and other surgical interventions needed for wound debridement, vascular by-pass, and reconstructive graft and flap surgeries in the same patient population.
Our equipment package includes two temperature controlled BARA-MED monoplace hyperbaric chambers and patented ancillary support equipment necessary to connect to the hospitals existing air and cryogenic oxygen supply systems, computer-based documentation system with complete protocols, patient data and digital photography for wound documentation.
What is Hyperbaric Oxygen Therapy ? BACK TO TOP
Hyperbaric Oxygen is a FDA-approved medical therapy modality wherein the patient breathes 100% oxygen at absolute pressures that are two to three times greater than normal atmospheric pressure. This is a systemic delivery of oxygen that produces up to a 22-fold increase in arterial plasma oxygen concentration.
This produces arterial oxygen tensions of up to 2,000 mmHg, which increases the diffusion distance from functioning capillaries by up to 6 times. HBOT is not to be confused with “topical” oxygen delivery using a box or tent arrangement, which is neither FDA approved nor reimbursed by CMS.
Reimbursed Indications BACK TO TOP
The Undersea and Hyperbaric Medical Society has developed
a list of medical indications where HBOT is considered the
Standard of Care, or where HBO has demonstrated efficacy as
an adjunctive treatment. The use of HBOT in these indications
is Medicare and commercially reimbursed.
Standard of Care BACK TO TOP
• Acute Severe Carbon Monoxide Poisoning; includes
smoke inhalation, cyanide poisoning
• Chronic Osteomyelitis, refractory to bone cultured
antibiotics and debridement
• Cerebral Arterial Gas Embolism; diver decompression or
surgically induced
• Radiation Tissue Injury; bone and soft tissue
complications
• Decompression Sickness; systemic inert gas (nitrogen)
bubbles
• Gas Gangrene; Clostridial myonecrosis and myositis
• Osteoradionecrosis, particularly of the mandible
Adjunctive Therapy BACK TO TOP
• Enhancement of Healing; select hypoxic wounds
compromised grafts and flaps
• Exceptional Blood Loss Anemia; patient refusal
of blood, difficult cross matching
• Diabetic Ulcers; Wagner grade 3+ that have
failed 30 days conventional therapy
• Necrotizing Soft Tissue Infections; subcutaneous
tissue, muscle, fascia
• Crush Injury; compartment syndrome and other
acute ischemia
• Thermal Burns; acute management, reduces
need for fluid resuscitation
• Intracranial Brain Abscess; including subdural
and epidural empyema
|
On the Horizon BACK TO TOP
Investigational indications for HBOT include the treatment of myocardial infarction in conjunction with clot-dissolving drugs such as TPA. Institutional research presently underway includes the adjunctive use of HBOT in cases of cardiovascular accidents, traumatic brain injury, spinal cord injury, HIV, Cerebral Palsy and refractory Lyme disease.
|
